Cross-Sector entity
Adam Alanoff is the most frequent co-covered peer, appearing in 3 of the 4 tracked stories. The clearest coverage concentration is earnings: 2 of 4 stories, with the rest divided among 2 other categories. The tracked stories average 2 original sources each.
4 verified stories tracked
Last mentioned: Feb 26, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Adam Alanoff is the most frequent co-covered peer, appearing in 3 of the 4 tracked stories. The clearest coverage concentration is earnings: 2 of 4 stories, with the rest divided among 2 other categories. The tracked stories average 2 original sources each. Padraig McDonnell appears in 4 tracked Cross-Sector stories from February 26, 2026.
Computed from the 4 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Padraig McDonnell. Shared-story counts are live from our verified record — not editorial picks.
Agilent reported a resilient first quarter despite weather disruptions and tariff-driven margin pressure, while TJX capped a record fiscal year with $60.4 billion in sales. Both companies highlighted shifting consumer and industrial demand, with Agilent navigating soft academic markets and TJX leveraging inventory flexibility to drive 5% comparable sales growth.
Agilent reported a 4.4% core revenue growth in Q1 2026, driven by a strong 7% uptick in the pharmaceutical sector despite an 8% decline in academic and government markets. The company is navigating margin pressures from new tariffs while leaning into high-growth areas like GLP-1 manufacturing and CDMO services.
TJX Companies achieved a milestone $60.4 billion in annual sales, driven by a 5% comparable sales increase and improved shrink management. Conversely, Agilent Technologies reported a 100-basis point gross margin decline due to tariff headwinds and softening demand in government-funded sectors.
Agilent Technologies reported a resilient Q1 2026 with $1.8 billion in revenue, driven by a 7% growth in the pharma sector despite significant headwinds in academic and government funding. While the company faced a 100-basis-point gross margin compression due to rising tariffs and weather disruptions, strong performance in the Agilent CrossLab Group suggests a shift toward service-oriented recurring revenue.
Source: Motley Fool Transcribing (us) · Motley Fool Transcribing (us)
